drugset / Trial / NCT01598363

An Open-Label Study of the Effect of Bardoxolone Methyl on the Single Dose Pharmacokinetics of Digoxin and Rosuvastatin in Healthy Volunteers

NCT01598363 ↗

Phase 1 Completed 32 enrolled Biogen
RandomizedParallel-groupOpen-labelBasic science

Summary

The purpose of this study is to evaluate the potential effect of bardoxolone methyl on the pharmacokinetics of digoxin and rosuvastatin and to assess the safety of the concomitant administration of bardoxolone methyl with digoxin or rosuvastatin.

Timeline

Start
2012-06-30
Primary completion
2012-07-31
Completion
2012-07-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Digoxin Other / unclassified 0.5 mg Oral
Subject Rosuvastatin Small molecule 20 mg Oral

Indications

No indication recorded.